DOUGLAS E. WILLIAMS - 24 Jan 2023 Form 4 Insider Report for Codiak BioSciences, Inc. (CDAKQ)

Role
President & CEO, Director
Signature
/s/ Yalonda Howze, Attorney-in-Fact for Douglas E. Williams
Issuer symbol
CDAKQ
Transactions as of
24 Jan 2023
Net transactions value
$0
Form type
4
Filing time
26 Jan 2023, 15:15:23 UTC
Previous filing
23 Jan 2023
Next filing
30 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDAKQ Stock Option (Right to Buy) Award $0 +465,000 $0.000000 465,000 24 Jan 2023 Common Stock 465,000 $0.7400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on January 24, 2024, with the remainder vesting in 12 equal quarterly installments thereafter.